Todd Bazemore's Net Worth

$1.17 Million

Estimate Recalculated Dec 3, 2025 07:32PM EST

Who is Todd Bazemore

Todd Bazemore has an estimated net worth of $1.17 Million. This is based on reported shares across multiple companies, which include Pulmatrix, Inc., KALA BIO, Inc., and DYAX CORP.

SEC CIK

Todd Bazemore's CIK is 0001605767

Past Insider Trading and Trends

2023 was Todd Bazemore's most active year for acquiring shares with 6 total transactions. Todd Bazemore's most active month to acquire stocks was the month of December. 2023 was Todd Bazemore's most active year for disposing of shares, totalling 9 transactions. Todd Bazemore's most active month to dispose stocks was the month of April. 2017 saw Todd Bazemore paying a total of $3,371,200.00 for 172,000 shares, this is the most they've acquired in one year. In 2015 Todd Bazemore cashed out on 99,750 shares for a total of $1,015,623.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pulmatrix, Inc.

Investor
Updated Jan 30, 2023
Form 4
1.70K
Jan 30, 2023
1.70K
Grant
Jan 26
Form 4
22.10K
Jan 28, 2022
22.10K
Grant
Jan 27
Form 4
15.00K
Feb 01, 2021
15.00K
Grant
Jan 28
Form 4
30.00K
Oct 02, 2020
30.00K
Grant
Oct 01
Form 3
Oct 02, 2020
Showing 5 results

KALA BIO, Inc.

SEE REMARKS
Updated Jun 27, 2024
Form 4
-5.31%
-4.65K
$4.75
-$22.10K
Jun 27, 2024
83.04K
Sale
Jun 26
Form 4
-2.33%
-2.09K
$6.09
-$12.75K
Jun 03, 2024
87.69K
Sale
May 31
Form 4
34.40K
$6.74
-$9.47K
Jan 05, 2024
42.62K
Grant
Jan 04
Form 4
315.70%
113.63K
Jun 23, 2023
149.62K
Grant
Jun 22
Form 4
Jun 02, 2023
35.99K
Acq/Dis
May 31
Form 4
576.00
Mar 15, 2023
576.00
Grant
Mar 14
Form 4
607.44%
12.74K
$28.54
-$1.77K
Jan 06, 2023
14.84K
Grant
ScheduledJan 04
Form 4
-9.26%
-214.00
$6.51
-$1.39K
Oct 28, 2022
2.10K
Sale
ScheduledOct 26
Form 4
-2.61%
-3.09K
$0.37
-$1.14K
Jun 29, 2022
115.54K
Sale
ScheduledJun 27
Form 4
192.18%
234.55K
$1.30
-$4.49K
Jan 05, 2022
356.63K
Grant
ScheduledJan 03 - Jan 04
Form 4
-9.32%
-12.54K
$1.80
-$22.58K
Oct 28, 2021
122.09K
Sale
ScheduledOct 26
Form 4
-11.10%
-2.91K
$5.77
-$16.80K
Jun 29, 2021
23.37K
Sale
ScheduledJun 28
Form 4
125.00%
137.50K
Jan 05, 2021
247.54K
Grant
Jan 04
Form 4
279.46%
81.04K
$7.88
$330.78
Oct 28, 2020
110.04K
Purchase
Jun 05 - Oct 26
Form 4
190.00%
19.00K
Jun 29, 2020
29.00K
Grant
Jun 25
Form 4
10.00K
$5.75
$57.50K
Mar 17, 2020
10.00K
Purchase
Mar 16
Form 4
120.00K
Jan 03, 2020
120.00K
Grant
Jan 02
Form 4
175.00K
Oct 15, 2019
175.00K
Grant
Oct 12
Form 4
175.00K
Jan 04, 2019
175.00K
Grant
Jan 02
Form 4
25.00K
Feb 09, 2018
25.00K
Grant
Feb 07
Form 4
172.00K
$19.60
$3.37M
Nov 21, 2017
172.00K
Grant
Nov 20
Form 3
Nov 21, 2017
Showing 22 results

DYAX CORP

EVP & Chief Commercial Officer
Updated Jan 22, 2016
Form 4
-100.00%
-457.00K
Jan 22, 2016
Disposition
Jan 22
Form 4
$6.80
$93.50K
Aug 19, 2015
207.00K
Options
Aug 18
Form 4
-17.20%
-43.00K
$15.21
-$723.22K
Aug 06, 2015
207.00K
Sale
Aug 04 - Aug 05
Form 4
250.00K
Feb 20, 2015
250.00K
Grant
Feb 18
Form 4
250.00K
Apr 18, 2014
250.00K
Grant
Apr 16
Form 3
Apr 18, 2014
Showing 6 results